MD2518G2 - Medicamental preparation for reducing the cholesterol concentration in the blood - Google Patents

Medicamental preparation for reducing the cholesterol concentration in the blood

Info

Publication number
MD2518G2
MD2518G2 MDA20030284A MD20030284A MD2518G2 MD 2518 G2 MD2518 G2 MD 2518G2 MD A20030284 A MDA20030284 A MD A20030284A MD 20030284 A MD20030284 A MD 20030284A MD 2518 G2 MD2518 G2 MD 2518G2
Authority
MD
Moldova
Prior art keywords
medicamental
reducing
blood
preparation
cholesterol concentration
Prior art date
Application number
MDA20030284A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2518F1 (en
Inventor
Элеонора ВАТАМАН
Виктор ПРИСКУ
Вавил КАРАДЖИЯ
Лидия ПАРШАКОВА
Original Assignee
Элеонора ВАТАМАН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Элеонора ВАТАМАН filed Critical Элеонора ВАТАМАН
Priority to MDA20030284A priority Critical patent/MD2518G2/en
Publication of MD2518F1 publication Critical patent/MD2518F1/en
Publication of MD2518G2 publication Critical patent/MD2518G2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to the medicamental preparations, which can be used in cardiology for reducing the lipoproteids of low density (LDL - cholesterol), the total cholesterol and the triglycerides in the blood serum that leads to the prevention and treatment of cardiovascular diseases caused by atherosclerosis.Summary of the invention consists in that the medicamental preparation contains soya protein, apple pectin, in the ratio of 7:1, calcium chloride and water, in the following component ratio, mass %:
MDA20030284A 2003-12-09 2003-12-09 Medicamental preparation for reducing the cholesterol concentration in the blood MD2518G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030284A MD2518G2 (en) 2003-12-09 2003-12-09 Medicamental preparation for reducing the cholesterol concentration in the blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030284A MD2518G2 (en) 2003-12-09 2003-12-09 Medicamental preparation for reducing the cholesterol concentration in the blood

Publications (2)

Publication Number Publication Date
MD2518F1 MD2518F1 (en) 2004-08-31
MD2518G2 true MD2518G2 (en) 2005-06-30

Family

ID=32906664

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030284A MD2518G2 (en) 2003-12-09 2003-12-09 Medicamental preparation for reducing the cholesterol concentration in the blood

Country Status (1)

Country Link
MD (1) MD2518G2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183964C2 (en) * 1997-07-30 2002-06-27 Индена С.П.А. Soybean extract, method of its preparation and pharmaceutical composition
AU767245B2 (en) * 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183964C2 (en) * 1997-07-30 2002-06-27 Индена С.П.А. Soybean extract, method of its preparation and pharmaceutical composition
AU767245B2 (en) * 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases

Also Published As

Publication number Publication date
MD2518F1 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
SG152271A1 (en) Immunemodulating oligosaccharides
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
MXPA05011886A (en) Methods and compositions for the prevention and treatment of sepsis.
EP2322201A3 (en) Compositions and methods for the treatment of immune related diseases
MX349188B (en) Sns-595 and methods of using the same.
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
EP1252824A3 (en) Method for improving bone mineralization
ES2195866T3 (en) MULTIUS ACID COMPOSITIONS.
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
DE60130464D1 (en) PRE-ADIPOSE CELL LINES
GB0124145D0 (en) Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2004058268A3 (en) Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
IL175358A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
MD2518G2 (en) Medicamental preparation for reducing the cholesterol concentration in the blood
PL377578A1 (en) The use of lupin conglutin for the treatment of type ii diabetes
UA85548C2 (en) Use of aqueous extract of red vine leaves for preventing transition from clinically insignificant early stages of chronic venous insufficiency to stages i, ii or iii
ATE412903T1 (en) DIAGNOSTICS AND THERAPY METHODS OF C5A RECEPTOR-RELATED DISEASES
EE05412B1 (en) Method for screening probiotic strains of the Bifidobacterium family
IL175357A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
MD2323F1 (en) Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
WO2002055694A3 (en) Discriminative nucleic acid analysis using clone sequence signatures
JPS6143978A (en) Method of deodorizing vegetable juice
Furuta et al. P-215 DESIGN AND SYNTHESIS OF NOVEL ACROMELIC ACID ANALOGS THAT REGULATE ALLODYNIC RESPONSES

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
NF4A Restoration of lapsed patent for invention
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees